Obecabtagene autoleucel
Autolus
['tecartus']
#autl presented very impressive ph2 data in b-all yesterday at #asco2023 obe-cel s safety profile looks set to be best in class and offers firm competition to tecartus in a high risk patient population. full analysis from our team below 
Immunology PhD researcher at UCL’s Great Ormond Street Institute of Child Health. Interested in CAR-T cell development for AML.